NPM1 Upregulates the Transcription of PD-L1 and Suppresses T Cell Activity in Triple-Negative Breast Cancer

Nature Communications - United Kingdom
doi 10.1038/s41467-020-15364-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PD-L1 Expression in Triple-Negative Breast Cancer

Cancer immunology research
Cancer ResearchImmunology
2014English

7. PD-L1 in Triple Negative Breast Cancer – Optimal Testing for Therapeutic Efficacy

Pathology
Forensic MedicinePathology
2020English

The Association of Genomic Lesions and PD-1/PD-L1 Expression in Resected Triple-Negative Breast Cancers

Breast Cancer Research
Cancer ResearchOncology
2018English

Selumetinib Suppresses Cell Proliferation, Migration and Trigger Apoptosis, G1 Arrest in Triple-Negative Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

In Vitro Antineoplastic Activity in Triple-Negative Breast Cancer Cell Line and in Vivo

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2014English

MicroRNA‑124 Suppresses Cell Proliferation and Invasion of Triple Negative Breast Cancer Cells by Targeting STAT3

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Triple-Negative Breast Cancer

2018English

T‑cadherin Is Associated With Prognosis in Triple‑negative Breast Cancer

Oncology Letters
Cancer ResearchOncology
2017English

MicroRNA-203 Suppresses Cell Proliferation and Migration by Targeting BIRC5 and LASP1 in Human Triple-Negative Breast Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy